Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.47 |
| ▸ | HPGD | P15428 | 7/20 | 0.47 |
| ▸ | YEATS4 | O95619 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 4/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19396257 | 0.87 | L3MBTL3 (0.62) | ALDH1A1HPGDL3MBTL3L3MBTL1 | |
| SCHEMBL19396275 | 0.86 | ALDH1A1 (0.43) | MAPTRXFP1ALDH1A1HPGDYEATS4 | |
| SCHEMBL12589838 | 0.86 | MAPK14 (0.49) | MAPTRXFP1ALDH1A1HPGDMAPK14 | |
| SCHEMBL12589841 | 0.85 | ALDH1A1 (0.46) | MAPTRXFP1ALDH1A1MAPK14NPC1 | |
| SCHEMBL19396274 | 0.85 | ALDH1A1 (0.42) | MAPTRXFP1ALDH1A1HPGDYEATS4 | |
| SCHEMBL1594311 | 0.85 | ALDH1A1 (0.43) | MAPTRXFP1ALDH1A1HPGDYEATS4 | |
| SCHEMBL12589846 | 0.85 | L3MBTL1 (0.51) | MAPTRXFP1ALDH1A1HPGDPOLB | |
| SCHEMBL19396277 | 0.85 | L3MBTL1 (0.51) | MAPTRXFP1ALDH1A1HPGDPOLB | |
| SCHEMBL19396276 | 0.85 | L3MBTL1 (0.51) | MAPTRXFP1ALDH1A1HPGDPOLB | |
| SCHEMBL19396252 | 0.85 | ALDH1A1 (0.41) | ALDH1A1YEATS4MAPK14NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170273968-A1 | MAO-B INHIBITORS AND REHABILITATION | DART NEUROSCIENCE, LLC | 2017-09-28 | — | — | US | disclosed |
| WO-2016044635-A1 | MAO-B INHIBITORS AND REHABILITATION | DART NEUROSCIENCE, LLC (US) | 2016-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170273968-A1 | MAO-B INHIBITORS AND REHABILITATION | MAOB, MAOA, HTR2B | MAPT 807/4885RXFP1 1369/4885ALDH1A1 1300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.